http://rdf.ncbi.nlm.nih.gov/pubchem/patent/YU-19302-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4dac022280ec96f54c694eb427655932
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J9-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J43-003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0055
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J41-00
filingDate 2000-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03980b4f53f8922b4cbfc1a5f30953f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20038d43d6ca0c7b57cda2d55ca205ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f54e719bf485fcca4284ed960b94c384
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2345f813f68efc9efee4c9fd545be12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4f110267d6cc22a13a1e8535803dc00
publicationDate 2004-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber YU-19302-A
titleOfInvention 4-Benzylaminoquinoline Conjugated with Bile Acid and Its Heteroanaloges
abstract The invention relates to substituted 4-benzylaminoquinoline and its heteroanalogues, as well as to their pharmaceutically acceptable salts and physiologically functional derivatives. Described are compounds of Formula I, wherein the residues have the meanings indicated, as well as their physiologically acceptable salts, physiologically functional derivatives and processes for their production. The compounds are suitable, for example, as medicaments for the prophylaxis or treatment of gallstones. and their physiologically functional derivatives. The invention also relates to methods for producing said compounds. These compounds are suitable for use e.g. as medicaments for preventing or treating gall stones.
priorityDate 1999-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409341052
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12299323

Total number of triples: 30.